Debra L. Ondeyka

A new class of angiotensin-converting enzyme inhibitors

Arthur A. Patchett, Elbert E. Harris, Edward W. Tristram et al. · Nature · 1980 · 706 citations

Medicine, Medicinal Chemistry, Pharmacology +8

Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists

Nathan B. Mantlo, Prasun K. Chakravarty, Debra L. Ondeyka et al. · Journal of Medicinal Chemistry · 1991 · 161 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells

Richard Saperstein, Pasquale P. Vicario, H.V. Strout et al. · Biochemistry · 1989 · 108 citations

Life Sciences, Endocrinology, Pharmacology +17

In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.

Peter K. S. Siegl, R S Chang, Nathan B. Mantlo et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 95 citations

Medicine, Pharmacology, Clinical Pharmacology +8

Effects of Subtype-Selective and Balanced Angiotensin II Receptor Antagonists in a Porcine Coronary Artery Model of Vascular Restenosis

William R. Huckle, Marlene Drag, Wayne R. Acker et al. · Circulation · 1996 · 69 citations

Medicine, Cardiology, Pharmacology +12